Stay updated on FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial page.

Latest updates to the FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedLocations are consolidated into a single Locations section listing sites in Arizona, Colorado, Florida, Illinois, Iowa, Massachusetts, Michigan, Missouri, New Jersey, New York, Texas, Utah, Wisconsin, and Victoria; the per-location subsections were removed, and the update is labeled Revision: v3.3.3.SummaryDifference1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.3.2 has been added and v3.2.0 removed.SummaryDifference0.0%

- Check36 days agoChange DetectedRemoved the government funding lapse notice related to NIH operations. Study details and locations remain unchanged.SummaryDifference0.3%

- Check51 days agoChange DetectedNo significant changes were observed in the page content, including study design, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check79 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference3%

- Check86 days agoChange DetectedAdded new medical topics on bile duct conditions and updated the revision version from v3.0.2 to v3.1.0.SummaryDifference0.7%

Stay in the know with updates to FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial page.